DNA微阵矩技术研究肝纤维化差异基因表达谱变化

吴诗品; 刘真真; 周俊; 黄明辉

DNA微阵矩技术研究肝纤维化差异基因表达谱变化

1. 暨南大学第二临床医学院深圳市人民医院感染内科
2. 香港城市大学深圳研究院

详细信息

中图分类号: R575.2
计量
- 文章访问数: 2464
- HTML全文浏览量: 14
- PDF下载量: 846
- 被引次数: 0
出版历程
- 出版日期: 2007-04-20

Analysis of differential gene expression profiles in hepatic fibrosis tissue using cDNA microarray

摘要

摘要: 应用DNA微阵矩技术研究乙型肝炎肝硬化组织差异基因表达谱改变,以寻找肝纤维化相关基因,探讨肝纤维化的发病机理。抽提正常肝组织和肝硬化组织中的mRNA来制备探针,经杂交、洗涤后,通过计算机扫描分析正常肝组织和肝硬化组织基因表达谱的差异情况。在10000个候选基因中,筛选出99条差异表达基因,表达上调的有45条,表达下调的有54条。其中未知基因9条。因此基于DNA微阵矩技术的肝纤维化基因表达谱分析能够高通量筛选与肝纤维化发生发展相关的基因。
- 寡核苷酸序列分析 /
- 基因表达 /
- 肝硬化
Abstract: To investigate the differentially expressed genes in hepatic fibrosis tissues using cDNA microarray and screen for fibrosis-related genes.Total RNA was extracted from normal human liver tissues and liver cirrhosis tissues.The mRNA was used to prepare probes.The mixed probes were hybridized to the cDNA microarray.After washing, the DNA chips were scanned by laster scanner.The acquired image was analyzed.Among the 10.000 target genes, 99 genes were identified in liver cirrhosis tissues that were either over or under-expressed as compared to controls.45 genes were up-regulated and 54 down-regulated.9 new genes were found in the study.The results showed that the cDNA microarray for analysis of gene expression profile is a powerful method for screening hepatic fibrosis-related genes.
- oligonucleotide array sequence analysis /
- gene expression /
- liver cirrhosis

HTML全文

参考文献(11)

[1]Chomczynski P, Sacchi N.Single-step method of RNA isolation byacid guanidinum thiocyanate-phenol-chloroform extraction[J].A-nal Biochem, 1987, 162∶156-159.

[2]Schema WM, Shalon D, Davis RW, et al.Quantitative mornitoringof gene expression patterns with a complementary DNAmicroarray[J].Science, 1995, 270∶467-470.

[3]Schema M, Shalon D, Heller R, et al.Parallel human genome anal-ysis:microarray-based expression monitoring of 1000 genes[J].Proc Natl Acad Sci USA, 1996, 93∶10614-10619.

[4]强晖, 谢渭芬, 张忠兵, 等.基因芯片技术研究肝纤维化相关基因[J].肝脏, 2003, 8∶5-8.

[5]Nejjari M, Couvelard A, Mosnier JF, et al.Integrin up-regulationin chronic liver disease:relationship with inflammation and fibrosis inchronic hepatitis C[J].J Pathol, 2001, 195∶473-481.

[6]Takabura T, Furui K, Funaki J, et al.Increased expression of ma-trix matalloproteinase-Ⅱin experimental liver fibrosis in rats[J].Hepatology, 1995, 21∶787-795.

[7]Gressner AM, Weiskirchem R, Breitkopf K, et al.Roles of TGF-bata in hepatic fibrosis[J].Front Biosci, 2002, 7∶793-807.

[8]Kitamura Y, Ninomiya H.Smad expression of hepatic stellate cells inliver cirrhosis in vivo and hepatic stellate cell line in vitro[J].PatholInt, 2003, 53∶18-26.

[9]George J, Roulot D, Koteliansky VE, et al.In vivo inhibition of ratstellate cell activation by soluble transforming growth factor beta type-Ⅱreceptor:a potential new therapy for hepatic fibrosis[J].ProcNatl Acad Sci USA, 1999, 96∶12719-12724.

[10]Canbay A, Taimr P, Torok N, et al.Apoptotic body engulfment bya human stellate cell line is profibrogenic[J].Lab Invest, 2003, 83∶655-663.

[11]Murphy FR, Issa R, Zhou X, et al.Inhibition of apoptosis of acti-vated hepatic stellate cells by tissue inhibition of metalloproteinase Iis mediated via effects on matrix metalloproteinase inhibition:impli-cations for reversibility of liver fibrosis[J].J Biol Chem, 2002, 277∶11069-11076.

施引文献

资源附件(0)

访问统计